Medtronic (MDT) Short term Debt (2014 - 2026)

Medtronic has disclosed Short term Debt across 13 years of filings, most recently posting $2.5 billion for Q3 2026.

• In Q3 2026, Short term Debt rose 4.36% year-over-year to $2.5 billion; the TTM figure through Jul 2026 stood at $2.5 billion (up 4.36% YoY), while the FY2026 annual figure was $1.8 billion, down 37.79% from the prior year.
• Short term Debt came in at $2.5 billion for Q3 2026 at Medtronic, up from $1.8 billion in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $5.9 billion in Q1 2023 to a low of $20.0 million in Q2 2023.
• Average Short term Debt over 5 years is $2.4 billion, with a median of $1.8 billion recorded in 2026.
• Year-over-year, Short term Debt surged 95383.33% in 2022 and slumped 99.47% in 2023.
• Over 5 years, Short term Debt stood at $5.9 billion in 2022, then sank by 77.17% to $1.3 billion in 2023, then surged by 177.74% to $3.7 billion in 2024, then plunged by 61.82% to $1.4 billion in 2025, then soared by 78.59% to $2.5 billion in 2026.
• Per Business Quant data, the three most recent Short term Debt figures were $2.5 billion in Q3 2026, $1.8 billion in Q2 2026, and $191.0 million in Q1 2026.